-transparent.png){kind=logo}
A single 1.0-g dose of cefaclor administered to patients with stable end stage renal disease whose creatinine clearances were <5 ml/min produced a mean peak serum concentration of 48.3 +/- 19.8 mug/ml. The half-life was 2.3 +/- 0.3 h. Hemodialysis shortened the half-life of a similar dose to 1.6 +/- 0.3 h. Approximately one-third (340 mg) of the administered drug was recovered in the dialysate. Multiple doses of 500 mg every 6 h between hemodialysis sessions produced effective serum concentrations and no bioassay evidence of drug accumulation.
Related Publications
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
January 1988,
Chemotherapy,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
March 1995,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
August 2018,
BMC ophthalmology,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
May 1999,
Pharmacotherapy,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
September 2000,
Clinical pharmacology and therapeutics,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
November 2010,
Anesthesia and analgesia,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
July 2014,
Epilepsy research,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
January 2017,
The journal of vascular access,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
December 2006,
Nature clinical practice. Nephrology,
S J Berman, and
W H Boughton, and
J G Sugihara, and
E G Wong, and
M M Sato, and
A W Siemsen
January 2002,
The Journal of international medical research,
